BlackRock, Inc. 13D and 13G filings for OptimizeRx Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
1,134,954 6.300% |
93,216 (+8.95%) |
Filing |
| 2023-04-06 09:29 am Sale |
2023-03-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
1,041,738 6.100% |
-1,672,452 (-61.62%) |
Filing |
| 2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
2,714,190 15.800% |
46,102 (+1.73%) |
Filing |
| 2022-01-27 5:13 pm Unchanged |
2021-12-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
2,668,088 15.000% |
0 (Unchanged) |
Filing |
| 2022-01-26 09:16 am Purchase |
2021-12-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
2,668,088 15.000% |
67,317 (+2.59%) |
Filing |
| 2021-11-24 3:40 pm Unchanged |
2021-10-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
2,600,771 14.800% |
0 (Unchanged) |
Filing |
| 2021-11-10 09:43 am Purchase |
2021-10-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
2,600,771 14.800% |
1,615,661 (+164.01%) |
Filing |
| 2021-01-29 5:22 pm Purchase |
2020-12-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
985,110 6.500% |
46,674 (+4.97%) |
Filing |